Vandetanib 25 mg | 98.83%
TargetMol
Vandetanib is a potent inhibitor of VEGFR2 (IC50: 40 nM). It also inhibits VEGFR3 and EGFR.
More Information Supplier PageVandetanib
Search Results
6-OAU 10 mg | Purity Not Available
TargetMol
6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with an EC50 of 105 nM in the PI assay.
More Information Supplier Page6-OAU
6-OAU 2 mg | Purity Not Available
TargetMol
6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with an EC50 of 105 nM in the PI assay.
More Information Supplier Page6-OAU
6-OAU 5 mg | Purity Not Available
TargetMol
6-OAU(GTPL5846; 6-n-octylaminouracil) is a surrogate agonist of GPR84; activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with an EC50 of 105 nM in the PI assay.
More Information Supplier Page6-OAU
Lumacaftor 100 mg | 99.72%
TargetMol
VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).
More Information Supplier PageLumacaftor
Lumacaftor 10 mg | 99.72%
TargetMol
VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).
More Information Supplier PageLumacaftor
Lumacaftor 50 mg | 99.72%
TargetMol
VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).
More Information Supplier PageLumacaftor
Lumacaftor 5 mg | 99.72%
TargetMol
VX-809 is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM).
More Information Supplier PageLumacaftor
SGC0946 10 mg | 99.82%
TargetMol
SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.
More Information Supplier PageSGC0946
SGC0946 25 mg | 99.82%
TargetMol
SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.
More Information Supplier PageSGC0946